Medical electrical lead having controlled texture surface and method of making same

• US 6,549,811 B2
• Filed: 01/12/2001
• Issued: 04/15/2003
• Est. Priority Date: 11/19/1998
• Status: Expired due to Fees

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Iverson, Vernon B., Taylor, Catherine E., Stewart, Mark T., Keeney, Kenneth W.
• Primary Examiner(s): Jastrzab, Jeffrey R.
• Application Number:
  US09/760,077
• Publication Number:
  US 20010029395A1
• Time in Patent Office: 823 Days
• Field of Search: 607/115, 607/116, 607/119, 607/120-122, 606/41, 600/372, 600/381, 295/921, 427/2.24, 427/2.25, 427/452, 427/257, 427/275
• US Class Current: 607/116
• CPC Class Codes: A61N 1/05 for implantation or insertion into the body, e.g. heart electrode A61N1/06 takes precedence
• CPC Class Codes: Y10T 29/49002 Electrical device making

Abstract

An elongate elastomeric structure having controlled surface texture. Plasma deposition is used to create controlled features, such as ridges, on the external surface of an elongate elastomeric surface, such as the external surface of silicone tubing. The invention has particular applicability in the medical device field, such as the fabrication of implantable leads, catheters, and medical devices incorporating them.

Claims

1. A method of texturing an external surface of an elongate elastomeric substrate for a medical lead, comprising:

stretching the elongate elastomeric substrate to yield a prestretched elongate elastomeric substrate;

continuously moving the prestretched elongate elastomeric substrate through a plasma deposition chamber; and

depositing at least one reactant monomer on at least one external surface of the prestretched elongate elastomeric substrate to form texture said external surface as the prestretched elongate elastomeric substrate moves through the plasma deposition chamber.

2. The method of claim 1, wherein the elongate elastomeric substrate comprises silicone and the prestretched elongate elastomeric substrate is moved through the plasma deposition chamber at a line speed of about 5 inches per minute to about 100 inches per minute.

3. The method of claim 1, wherein the elongate elastomeric substrate comprises silicone and is stretched by applying a tension of about 5 grams to about 100 grams to yield the prestretched elongate elastomeric substrate.

4. The method of claim 1, wherein the elongate elastomeric substrate comprises at least one material selected from the group consisting of silicone, polyurethane, polyisoprene and natural rubber.

5. The method of claim 4, wherein the elongate elastomeric substrate is silicone tubing.

6. The method of claim 1, wherein the reactant monomer comprises at least one of a siloxane and a silane.

7. The method of claim 6, wherein the reactant monomer comprises a siloxane selected from the group consisting of hexamethyldisiloxane (HMDSO), tetramethyidisiloxane (TMDSO) octamethylcyclotetrasiloxane, tetramethylcyclotetrasiloxane and hexamethylcyclotrisiloxane.

8. The method of claim 7, wherein the elongate elastomeric substrate is silicone tubing.

9. The method of claim 1, further comprising plasma pretreating the elongate elastomeric substrate prior to depositing the reactant monomer.

10. The method of claim 1, further comprising incorporating a bioactive molecule onto the textured external surface of the elongate elastomeric substrate.

11. The method of claim 1, wherein the surface texture comprises a multiplicity of micron scale surface features characterized by controlled spacing along the longitudinal axis of the elongate elastomeric substrate.

12. A method of making an elongate elastomeric structure for a medical lead, the elongate textured structure comprising a textured external surface, comprising:

stretching the elongate elastomeric structure to yield a prestretched elongate elastomeric structure;

continuously moving the prestretched elongate elastomeric structure through a plasma deposition chamber; and

depositing at least one reactant monomer on at least one external surface of the prestretched elongate elastomeric structure to form texture said external surface as the prestretched elongate elastomeric structure moves through the plasma deposition chamber to yield an elongate elastomeric structure comprising a textured external surface.

13. The method of claim 12, further comprising incorporating a bioactive molecules onto the textured external surface of the elongate elastomeric substrate to yield an elongate elastomeric structure comprising a textured external surface comprising a bioactive molecule.

14. The method of claim 12, wherein the elongate elastomeric structure comprises all or a portion of a lead or a catheter.

19. A textured elongate elastomeric structure made according to the method of claim 12.

20. The textured elongate elastomeric structure of claim 19, comprising silicone tubing, said textured elongate elastomeric structure having improved slip characteristics compared to non-textured silicone tubing.

21. The textured elongate elastomeric structure of claim 19, further comprising all or a portion of a lead or a catheter.

22. A medical device comprising an elongate elastomeric structure made according to the process of claim 12.

23. The medical device of claim 22, the medical device being selected form the group consisting of a pacemaker, a pacemaker-cardioverter-defibrillator, an implantable neurostimulator, an implantable nerve stimulator, a muscle stimulator, an implantable monitoring device, an implantable fluid handling device, a defibrillator, a cardioverter/defibrillator, a gastric stimulator, a drug pump and a hemodynamic monitoring device.

15. A method of texturing an external surface of an elastomeric substrate for a medical lead, comprising:

stretching the elastomeric substrate to yield a prestretched elastomeric substrate; and

depositing at least one reactant monomer on at least one external surface of the prestretched elastomeric substrate to form texture said external surface.

16. The method of claim 15, wherein the monomer is deposited for about 1 minute to about 30 minutes.

17. The method of claim 15, wherein the elastomeric substrate comprises silicone.

18. The method of claim 15, wherein the reactant monomer comprises at least one of a siloxane or a silane.

24. A method for making at least one of a medical lead and a medical catheter, comprising:

stretching elastomeric tubing comprising at least one lumen to yield prestretched elastomeric tubing;

continuously moving the prestretched elastomeric tubing through a plasma deposition chamber; and

depositing at least one reactant monomer to form texture on at least one external surface of the tensioned elastomeric tubing as the tubing moves through the plasma deposition chamber, to yield elastomeric tubing having at least one textured external surface;

fabricating the lead or catheter from said elastomeric tubing having the textured external surface.

25. The method of claim 24, wherein the elastomeric tubing comprises silicone tubing.

26. The method of claim 24, wherein the reactant monomer comprises at least one of a siloxane or a silane.

27. The method of claim 24, wherein the textured external surface of the elastomeric tubing comprises a multiplicity of micron scale surface features characterized by controlled spacing along the longitudinal axis of the elastomeric tubing.

28. A method of making at least one of a medical lead and a medical catheter, the lead and catheter having improved slip characteristics, comprising:

stretching silicone tubing comprising at least one lumen to yield prestretched silicone tubing;

continuously moving the prestretched silicone tubing through a plasma deposition chamber; and

depositing at least one reactant monomer to form texture on at least one external surface of the prestretched silicone tubing as the tubing moves through the plasma deposition chamber, to yield silicone tubing having at least one textured external surface;

fabricating the lead or catheter from said silicone tubing having the textured external surface.

29. The method of claim 28, wherein the reactant monomer comprises at least one of a siloxane and a silane.